Keratinocyte growth factor up-regulates Interleukin-7 expression following intestinal ischemia/reperfusion in vitro and in vivo

Int J Clin Exp Pathol. 2012;5(6):569-80. Epub 2012 Jul 29.

Abstract

Background: Epithelial cell (EC)-derived Interleukin-7 (IL-7) plays a crucial role in control of neighboring intestinal intraepithelial lymphocytes (IEL) development and homeostasis, and IEL derived keratinocyte growth factor (KGF) promotes intestinal epithelial growth, which was regulated by EC-derived IL-7. On this basis, we hypothesize that there is a crosstalk between IELs and ECs, and KGF could regulate the EC-derived IL-7 expression, which should be associated with the protective effects by KGF on intestinal injury.

Methods: Histological evaluation was performed in small intestine tissues of patients with intestinal obstruction and IL-7 expression was detected by immunofluorescence. Intestinal epithelial cells (LoVo) and adult C57BL/6J mice undergoing ischemia/reperfusion injury were treated with recombinant KGF. KGF, KGF receptor(KGFR) and IL-7 expressions were measured with western blot and immunofluorescence analysis.

Results: IL-7 expression increased in the mild ischemia while decreased in severe ischemia small intestinal tissues of patients with intestinal obstruction. KGF expression significantly decreased while IL-7 expression increased early after acute intestinal I/R administration in a mouse model. KGF treatment significantly increased the IL-7 expression both in vitro and in vivo, while when the KGFR was blocked, the findings above were absent. In addition, our results showed changes of IL-7 expression at different stages after acute intestinal I/R administration, KGF treatment significantly attenuated the decreasing of IL-7 expression caused by acute intestinal I/R.

Conclusion: KGF could up-regulate the IL-7 expression both in vitro and in vivo through KGFR pathway, which should have associated with the protective effects of KGF in intestinal injury.

Keywords: Keratinocyte growth factor; epithelial cells; interleukin-7; ischemia/reperfusion; mouse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Blocking / pharmacology
  • Cell Line, Tumor
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / pathology
  • Disease Models, Animal
  • Fibroblast Growth Factor 7 / pharmacology*
  • Humans
  • Interleukin-7 / metabolism*
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / pathology
  • Intestinal Obstruction / metabolism*
  • Intestinal Obstruction / pathology
  • Ischemia / metabolism*
  • Ischemia / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Receptor, Fibroblast Growth Factor, Type 2 / immunology
  • Receptor, Fibroblast Growth Factor, Type 2 / metabolism
  • Recombinant Proteins / pharmacology
  • Reperfusion Injury / metabolism*
  • Reperfusion Injury / pathology
  • Up-Regulation

Substances

  • Antibodies, Blocking
  • Interleukin-7
  • Recombinant Proteins
  • Fibroblast Growth Factor 7
  • Receptor, Fibroblast Growth Factor, Type 2
  • keratinocyte growth factor receptor